D-1083-2023 Class III Terminated

Recalled by B. Braun Medical Inc. — Daytona Beach, FL

FDA drug recall D-1083-2023 was initiated by B. Braun Medical Inc. on Aug 2, 2023 and is designated Class III. Reason for recall: Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed. The recall status is terminated (terminated Jul 7, 2025). Affected quantity: 43,812 bags.

Recall details

Product Type
Drugs
Report Date
Aug 16, 2023
Initiation Date
Aug 2, 2023
Termination Date
Jul 7, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
43,812 bags

Product description

0.9% Sodium Chloride Injection USP, 1000 mL Excel Plus Container, Rx only, B. Braun Medical Inc. Bethlehem, PA 18018, NDC 0264-5802-00

Reason for recall

Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed.

Distribution pattern

United States

Code information

Lot #: 0061852531, Exp 2/28/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1083-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1083-2023. Report a data issue: hello@regdatalab.com.